GlassScriptPhysician profile
Kent Yundt
NPI 1275518797
$4,382.34
in general payments reported to CMS, 2019-2025
12 companies · $316 in 2025
The $316 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,582 · 2020: $480 · 2021: $70.63 · 2022: $282 · 2023: $292 · 2024: $359 · 2025: $316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $967.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $967.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $2,845.85 | 2019-2024 | Senza |
| Boston Scientific Corporation | $457.33 | 2019-2025 | General - Pain Management, General - Therapies, Wavewriter Alpha Prime 16 |
| Nuvasive, INC. | $357.66 | 2019-2020 | |
| Cerapedics INC. | $196.25 | 2022-2024 | I-Factor Peptide Enhanced Bone Graft |
| Stryker Corporation | $186.30 | 2019-2025 | Universal Neuro 3, Direct Inject, Ivas |
| Abbott Laboratories | $105.24 | 2019-2025 | Penta, Eterna |
| Globus Medical, INC. | $88.97 | 2024-2025 | Excelsius3d Imaging System, Lateralalif |
| Relievant Medsystems, INC. | $44.18 | 2023 | Intracept |
| Radius Health, INC. | $33.78 | 2021 | |
| Mimedx Group, INC. | $31.13 | 2025 | |
| Medtronic, INC. | $23.43 | 2024 | Aquamantys(Tm) |
| Integra Lifesciences Corporation | $12.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kent Yundt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.